Human Influenza A/PR/8/34 (H1N1) Purified Virus, UV-Inactivated

Catalog #: 10-273-500

Size: 0.5 mg

This material requires a signed and fully executed Advanced Biotechnologies Inc agreement with possible fees, prior to purchase. To begin this process, please complete the Intended Use form and return it to agreements@abionline.com.

Intended Use Form

DETAILS RESOURCES RELATED PRODUCTS

Human Influenza A/PR/8/34 (H1N1) purified virus inactivated by ultraviolet light irradiation.

For research use only.

APPLICATION FOR USE

Hemagglutination Assay (HA)
ELISpot Assay
Hemagglutination Inhibition Assay (HAI)
Virus Ultrastructural Studies
Antibody Screening/Titration
Antibody Production
Lymphocyte Stimulation Assay

QUALITY CONTROL TESTING INCLUDES

Sterility
Validation of Inactivation
Hemagglutination Assay
Protein Concentration
VPC by TEM

SHIPPING AND STORAGE:

This product is shipped frozen on dry ice. Store at -70°C upon receipt. Avoid multiple freeze-thaw cycles as product degradation may result.

RECOMMENDATIONS:

Upon thawing, centrifuge the vial for a few seconds to remove residual droplets from the lid.

SAFE HANDLING RECOMMENDATIONS:

This inactivated biological preparation should be handled in accordance with biosafety guidelines defined in the BMBL, NIH-CDC HHS Publication No. (CDC) 21-1112.

DOCUMENTATION

Certificate of Analysis

Safety Data Sheet

300-10-273-500

REFERENCE ARTICLES

Dudhgaonkar, S., Ranade, S., Nagar, J., Subramani, S., Prasad, D., Karunanithi, P., Srivastava, R., Venkatesh, K., Selvam, S., and Krishnamurthy, P. et al. (2017). Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity. The Journal Of Immunology 198, 1308-1319. https://doi.org/10.4049/jimmunol.1600583

Koopman, G., Mooij, P., Dekking, L., Mortier, D., Nieuwenhuis, I., van Heteren, M., Kuipers, H., Remarque, E., Radoševi?, K., and Bogers, W. (2016). Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus. Journal Of Virology 90, 1023-1033. https://doi.org/10.1128/jvi.02757-15

Pugh, N., Edwall, D., Lindmark, L., Kousoulas, K., Iyer, A., Haron, M., and Pasco, D. (2015). Oral administration of a Spirulina extract enriched for Braun-type lipoproteins protects mice against influenza A (H1N1) virus infection. Phytomedicine 22, 271-276. https://doi.org/10.1016/j.phymed.2014.12.006

CATALOG #

PRODUCT NAME

SIZE

PRICE

PRODUCTS